Abstract
IntroductionChronic pain increases the risk of prescription opioid misuse or opioid use disorder (OUD). Non-pharmacological treatments are needed to dually address pain and opioid risks. The purpose of the Mobile and Online-Based Interventions to Lessen Pain (MOBILE Relief) study is to compare a one-session, video-based, on-demand digital pain relief skills intervention for chronic pain (‘Empowered Relief’ (ER); tailored to people at risk for opioid misuse or with opioid misuse/OUD) to a one-session digital health education intervention (‘Living Better’; no pain management skills).Methods and analysisMOBILE Relief is an international online randomised controlled clinical trial. Study participants are adults with chronic, non-cancer pain (≥6 months) with daily pain intensity ≥3/10, taking ≥10 morphine equivalent daily dose and score ≥6 on the Current Opioid Misuse Measure. Participants are recruited through clinician referrals and clinic advertisements. Study procedures include electronic eligibility screening, informed consent, automated 1:1 randomisation to the treatment group, baseline measures, receipt of assigned digital treatment and six post-treatment surveys spanning 3 months. Study staff will call participants at baseline and 1-month and 3 months post-treatment to verify the opioid prescription. The main statistical analyses will include analysis of covariance and mixed effects model for repeated measurements regression.Main outcomesPrimary outcomes are self-reported pain catastrophising, pain intensity, pain interference, opioid craving and opioid misuse at 1-month and 3 months post-treatment. We will determine the feasibility of ER (≥50% participant engagement, ≥70% treatment appraisal ratings). We hypothesise the ER group will be superior to the Living Better group in the reduction of multiprimary pain outcomes at 1-month post-treatment and opioid outcomes at 1-month and 3 months post-treatment.Ethics and disseminationThe study protocol was approved by the Stanford University School of Medicine Institutional Review Board (IRB 61643). We will publish results in peer-reviewed journals; National Institute of Drug Abuse (funder) and MOBILE Relief participants will receive result summaries.Trial registration numberNCT05152134.
Funder
National Institute of Neurological Disorders and Stroke
National Institute on Drug Abuse
Reference69 articles.
1. World drug report 2023. 2023. Available: https://www.unodc.org/unodc/en/data-and-analysis/world-drug-report-2023.html
2. Trends and Geographic Patterns in Drug and Synthetic Opioid Overdose Deaths - United States, 2013-2019;Mattson;MMWR Morb Mortal Wkly Rep,2021
3. Substance Abuse and Mental Health Services Administration . Key substance use and mental health indicators in the United States: results from the 2020 national survey on drug use and health. Center for Behavioral Health Statistics and Quality: Substance Abuse and Mental Health Services Administration; 2020.
4. Pain management best practices inter-agency task force report. 2019. Available: https://www.hhs.gov/sites/default/files/pmtf-final-report-2019-05-23.pdf
5. Centers for Disease Control . 2016. Available: https://www.cdc.gov/drugoverdose/prescribing/patients.html